We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
10 Year Est. Return
AUM
$6.18B
AUM Growth
+$1.08B
Cap. Flow
+$404M
Cap. Flow %
6.55%
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313

Sector Composition

Rank Sector Weight
1 Healthcare 53.16%
2 Consumer Discretionary 5.06%
3 Energy 4.01%
4 Utilities 3.23%
5 Financials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGLD icon
101
Royal Gold
RGLD
$16.8B
$11.8M 0.19%
187,988
+99,548
+113% +$6.12M
EXPE icon
102
Expedia Group
EXPE
$35.4B
$11.7M 0.19%
161,833
+158,213
+4,371% +$11.5M
ZBH icon
103
Zimmer Biomet
ZBH
$18.2B
$11.5M 0.19%
125,363
-191,512
-60% -$17.7M
SEMG
104
DELISTED
SEMGROUP CORPORATION
SEMG
$11.5M 0.19%
174,991
+129,267
+283% +$8.22M
DRC
105
DELISTED
DRESSER-RAND GROUP INC
DRC
$11.4M 0.18%
194,471
+91,778
+89% +$5.23M
MWIV
106
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$11.3M 0.18%
72,822
+68,752
+1,689% +$11.5M
MTW icon
107
Manitowoc
MTW
$497M
$11.3M 0.18%
397,226
+364,580
+1,117% +$9.34M
WX
108
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$11.1M 0.18%
+300,752
New +$11M
AWAY
109
DELISTED
HOMEAWAY INC COM
AWAY
$11M 0.18%
293,120
+142,107
+94% +$6M
PRXL
110
DELISTED
Parexel International Corp
PRXL
$11M 0.18%
202,797
-83,070
-29% -$4.26M
CBSH icon
111
Commerce Bancshares
CBSH
$8.53B
$10.4M 0.17%
403,622
+311,509
+338% +$7.74M
SXC icon
112
SunCoke Energy
SXC
$720M
$10.4M 0.17%
456,396
+248,016
+119% +$5.46M
TFX icon
113
Teleflex
TFX
$6.05B
$10.4M 0.17%
96,845
+8,696
+10% +$856K
EHC icon
114
Encompass Health
EHC
$11B
$10.3M 0.17%
359,246
+329,969
+1,127% +$8.59M
CMS icon
115
CMS Energy
CMS
$22.6B
$10.2M 0.16%
347,365
-177,351
-34% -$4.91M
DHR icon
116
Danaher
DHR
$137B
$10.2M 0.16%
201,720
-142,166
-41% -$7.24M
BDX icon
117
Becton Dickinson
BDX
$45.6B
$10.1M 0.16%
88,623
+65,307
+280% +$7.18M
URS
118
DELISTED
URS CORP
URS
$10.1M 0.16%
214,806
+139,526
+185% +$6.76M
VCYT icon
119
Veracyte
VCYT
$3.7B
$10M 0.16%
586,057
+139,007
+31% +$2.22M
WOOF
120
DELISTED
VCA Inc.
WOOF
$9.85M 0.16%
+305,699
New +$9.86M
ABAX
121
DELISTED
Abaxis Inc
ABAX
$9.72M 0.16%
+250,000
New +$9.91M
AA icon
122
Alcoa
AA
$11.9B
$9.72M 0.16%
314,188
+309,239
+6,249% +$8.59M
EL icon
123
Estee Lauder
EL
$30.4B
$9.69M 0.16%
144,800
+61,899
+75% +$4.3M
GNMK
124
DELISTED
GenMark Diagnostics, Inc
GNMK
$9.6M 0.16%
965,535
+48,324
+5% +$600K
MTD icon
125
Mettler-Toledo International
MTD
$28.6B
$9.41M 0.15%
+39,928
New +$9.77M

Similar funds

Visium Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.

  • Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
  • Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
  • Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
  • Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
  • Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
  • Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
  • Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.